Dia Spectr
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Diabetes Spectrum 21:209-214, 2008
DOI: 10.2337/diaspect.21.3.209
© 2008 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Ramser, K. L.
Right arrow Articles by Kuhl, D. A.
PubMed
Right arrow Articles by Ramser, K. L.
Right arrow Articles by Kuhl, D. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pharmacy Update

Physician-Pharmacist Collaboration in the Management of Patients With Diabetes Resistant to Usual Care

Kristie L. Ramser, PharmD, Laura R. Sprabery, MD, FACP, Christa M. George, PharmD, Gale L. Hamann, PharmD, Victor A. Vallejo, MD, Craig S. Dorko, MD, FACP and David A. Kuhl, PharmD

The first 300 words of the full text of this article appear below.


    Introduction
 
Diabetes affects 20.8 million Americans and accounts for $132 billion in direct and indirect health care costs per year.1 It is associated with numerous complications including heart disease, stroke, retinopathy, neuropathy, and nephropathy.

The Diabetes Control and Complications Trial and the U.K. Prospective Diabetes Study demonstrated the effectiveness of intensive glycemic control in the reduction of microvascular complications in patients with type 1 and type 2 diabetes, respectively.2,3 The American Diabetes Association (ADA) publishes annual clinical practice guidelines that recommend a general hemoglobin A (A1C) goal of < 7%, a total cholesterol goal of 1c < 200 mg/dl, an HDL cholesterol goal of > 40 mg/dl for men and > 50 mg/dl for women, a triglyceride goal of < 150 mg/dl, an LDL cholesterol goal of < 100 mg/dl, a systolic blood pressure goal of < 130 mmHg, and a diastolic blood pressure goal of < 80 mmHg.4

Despite the publication and wide distribution of these recommendations, many patients with diabetes still do not meet recommended treatment goals.5 Numerous barriers to care exist in the primary care setting. These barriers can be related to patients, providers, organizations, and public policy.69 Subsequently, patients with diabetes and other chronic diseases often receive suboptimal care in the outpatient setting.

When patients do not meet treatment goals, ADA recommends several interventions. Some of these include intensifying the treatment regimen, identifying barriers to adherence, and increasing frequency of patient contact.4 Multifaceted interventions targeting providers, patients, and organizations have been shown to improve the chronic care of patients with diabetes.8,10 Efforts should ultimately be focused on increasing patients' knowledge, skills, and confidence in managing their disease.11

Several studies have reported improvements in glycemic control through pharmacist intervention within collaborative practices,1215 case management,16 and interdisciplinary teams.17 Pharmacists have been involved in diabetes care for many years within the . . . [Full Text of this Article]


    Patients and Methods
 

    Results
 

    Discussion
 

    Conclusion
 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2008 by the American Diabetes Association.